mibefradil has been researched along with d 888 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bosse, E; Donatin, K; Flockerzi, V; Hofmann, F; Lacinova, L; Ludwig, A; Welling, A | 1 |
| Birnbaumer, L; Hofmann, F; Ito, H; Klugbauer, N; Lacinová, L; Schuster, A | 1 |
2 other study(ies) available for mibefradil and d 888
| Article | Year |
|---|---|
Expression of the L-type calcium channel with two different beta subunits and its modulation by Ro 40-5967.
Topics: Animals; Antibodies, Monoclonal; Benzimidazoles; Calcium Channel Blockers; Calcium Channels; CHO Cells; Cricetinae; Electrophysiology; Isradipine; Mibefradil; Muscle, Smooth; Stereoisomerism; Tetrahydronaphthalenes; Transfection; Verapamil | 1995 |
The IVS6 segment of the L-type calcium channel is critical for the action of dihydropyridines and phenylalkylamines.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Amino Acid Sequence; Benzimidazoles; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Cell Line; Humans; Ion Channel Gating; Isradipine; Mibefradil; Molecular Sequence Data; Muscle Proteins; Protein Structure, Tertiary; Recombinant Fusion Proteins; Sequence Alignment; Structure-Activity Relationship; Tetrahydronaphthalenes; Transfection; Verapamil | 1996 |